Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB11-binding protein RELCH (also known as KIAA1468) is a large intracellular protein that functions as a selective Rab11 effector. RELCH contains LisH, coiled-coil, and HEAT repeat domains, enabling it to interact directly with the small GTPase Rab11 (mainly Rab11a and Rab11b) and with oxysterol-binding protein (OSBP). Co-localizing at recycling endosomes, RELCH tethers these Rab11-positive membranes to the trans-Golgi network by bridging interactions with OSBP, thus facilitating the nonvesicular transport of cholesterol from recycling endosomes to the TGN. Genetic depletion studies in cell models demonstrate that RELCH is essential for normal intracellular cholesterol trafficking but is not directly implicated in broader vesicle transport or endocytosis. No evidence currently supports a direct therapeutic targeting role for RELCH, nor are there established pharmacologic agents or biomarkers related to this protein. Disease associations are limited but may include familial expansile osteolysis and familial medullary thyroid carcinoma via genetic database annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB11-binding protein RELCH (RELCH).